Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment

Behavioural Brain Research

Volumn 207, Issue 2, 2010, Pages 387-393

  Lu, Ping ^a,b,f   Mamiya, Takayoshi ^a,f   Lu, Lingling ^a,b,f   Mouri, Akihiro ^a,f   Niwa, Minae ^a,f   Kim, Hyoung Chun ^d   Zou, Li Bo ^b   Nagai, Taku ^c,f   Yamada, Kiyofumi ^c,f   Ikejima, Takashi ^b   Nabeshima, Toshitaka ^a,e,f  

^a MEIJO UNIVERSITY   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Kangwon National University   (South Korea)

^e Japanese Drug Organization of Appropriate Use and Research   (Japan)

^f The Academic Frontier Project for Private Universities   (Japan)

Author keywords

Dopamine; Memory; Methamphetamine; Serotonin; Silibinin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; METHAMPHETAMINE; SEROTONIN; SILIBININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG MECHANISM; DRUG SCREENING; HIPPOCAMPUS; LEARNING DISORDER; MALE; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECOGNITION; SEROTONIN BRAIN LEVEL; TASK PERFORMANCE; TISSUE LEVEL;

ANIMALS; BRAIN; COGNITION; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; MEMORY DISORDERS; METHAMPHETAMINE; MICE; MICE, INBRED ICR; NOOTROPIC AGENTS; PREFRONTAL CORTEX; RECOGNITION (PSYCHOLOGY); SEROTONIN; SILYMARIN;

EID: 74449084200     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.10.024     Document Type: Article

References (48)

1. Ara J., Przedborski S., Naini A.B., Jackson-Lewis V., Trifiletti R.R., Horwitz J., et al. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci USA 95 (1998) 7659-7663
2. Bar M. A cortical mechanism for triggering top-down facilitation in visual object recognition. J Cogn Neurosci 15 (2003) 600-609
3. Belcher A.M., O'Dell S.J., and Marshall J.F. Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacology 30 (2005) 2026-2034
4. Besheer J., Jensen H.C., and Bevins R.A. Dopamine antagonism in a novel-object recognition and a novel-object place conditioning preparation with rats. Behav Brain Res 103 (1999) 35-44
5. Broadbent N.J., Squire L.R., and Clark R.E. Spatial memory, recognition memory, and the hippocampus. Proc Natl Acad Sci USA 101 (2004) 14515-14520
6. Bryan-Lluka L.J., Papacostas M.H., Paczkowski F.A., and Wanstall J.C. Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT). Br J Pharmacol 143 (2004) 63-70
7. Buhot M.C., Martin S., and Segu L. Role of serotonin in memory impairment. Ann Med 32 (2000) 210-221
8. Cohen J.D., and Servan-Schreiber D.S. A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophr Bull 19 (1993) 85-104
9. Dalley J.W., Lääne K., Theobald D.E., Peña Y., Bruce C.C., Huszar A.C., et al. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsychopharmacology 32 (2007) 1195-1206
10. Dix S.L., and Aggleton J.P. Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition. Behav Brain Res 99 (1999) 191-200
11. Ichihara K., Nabeshima T., and Kameyama T. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice. Eur J Pharmacol 234 (1993) 155-163
12. Imam S.Z., el-Yazal J., Newport G.D., Itzhak Y., Cadet J.L., Slikker Jr. W., et al. Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann N Y Acad Sci 939 (2001) 366-380
13. Kafkas A., and Migo E.M. Familiarity and recollection in the medial temporal lobe. J Neurosci 29 (2009) 2309-2311
14. Kalechstein A.D., Newton T.F., and Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 15 (2003) 215-220
15. Kamei H., Nagai T., Nakano H., Togan Y., Takayanagi M., Takahashi K., et al. Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. Biol Psychiatry 59 (2006) 75-84
16. Kitanaka J., Kitanaka N., and Takemura M. Modification of monoaminergic activity by MAO inhibitors influences methamphetamine actions. Drug Target Insights 1 (2006) 19-28
17. Kitanaka J., Kitanaka N., and Takemura M. Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review. Neurochem Res 33 (2008) 204-219
18. Kuhn D.M., and Geddes T.J. Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity. J Biol Chem 274 (1999) 29726-29732
19. LaVoie M.J., Card J.P., and Hastings T.G. Microglial activation precedes dopamine terminal pathology in methamphetamine induced neurotoxicity. Exp Neurol 187 (2004) 47-57
20. Lu P., Mamiya T., Lu L.L., Mouri A., Nagai T., Hiramatsu M., et al. Silibinin prevents amyloid β peptide-induced memory impairment and oxidative stress in mice. Br J Pharmacol 157 (2009) 1270-1277
21. Lu P., Mamiya T., Lu L., Mouri A., Niwa M., Hiramatsu M., et al. Silibinin attenuates amyloid {beta}25-35 peptide-induced memory impairments: Implication of inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha (TNF-α) in mice. J Pharmacol Exp Ther 331 (2009) 319-326
22. Marshall J.F., Belcher A.M., Feinstein E.M., and O'Dell S.J. Methamphetamine-induced neural and cognitive changes in rodents. Addiction 102 (2007) 61-69
23. Mazzio E.A., Harris N., and Soliman K.F. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med 64 (1998) 603-606
24. Meeter M., Talamini L., Schmitt J.A., and Riedel W.J. Effects of 5-HT on memory and the hippocampus: model and data. Neuropsychopharmacology 31 (2006) 712-720
25. Mizoguchi H., Takuma K., Fukakusa A., Ito Y., Nakatani A., Ibi D., et al. Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology (Berl) 196 (2008) 233-241
26. Nagai T., Takuma K., Dohniwa M., Ibi D., Mizoguchi H., Kamei H., et al. Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology (Berl) 194 (2007) 21-32
27. Nagai T., Takuma K., Kamei H., Ito Y., Nakamichi N., Ibi D., et al. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex. Learn Mem 14 (2007) 117-125
28. Nordahl T.E., Salo R., and Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition. J Neuropsychiatry Clin Neurosci 15 (2003) 317-325
29. Osuchowski M., Johnson V., He Q., and Sharma R. Alterations in regional brain neurotransmitters by silymarin, a natural antioxidant flavonoid mixture, in BALB/c mice. Pharm Biol 42 (2004) 384-389
30. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 (2007) 315-424
31. Park S.B., Coull J.T., McShane R.H., Young A.H., Sahakian B.J., Robbins T.W., et al. Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33 (1994) 575-588
32. Park S.U., Ferrer J.V., Javitch J.A., and Kuhn D.M. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. J Neurosci 22 (2002) 4399-4405
33. Reed J.M., and Squire L.R. Impaired recognition memory in patients with lesions limited to the hippocampal formation. Behav Neurosci 111 (1997) 667-675
34. Riedel W.J., Klaassen T., Deutz N.E.P., van Someren A., and van Praag H.M. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl) 141 (1999) 362-369
35. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depeleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 20 (1999) 322-339
36. Sehatpour P., Molholm S., Schwartz T.H., Mahoney J.R., Mehta A.D., Javitt D.C., et al. A human intracranial study of long-range oscillatory coherence across a frontal-occipital-hippocampal brain network during visual object processing. Proc Natl Acad Sci USA 105 (2008) 4399-4404
37. Sekine Y., Ouchi Y., Sugihara G., Takei N., Yoshikawa E., Nakamura K., et al. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28 (2008) 5756-5761
38. Shanmugam K., Holmquist L., Steele M., Stuchbury G., Berbaum K., Schulz O., et al. Plant-derived polyphenols attenuate lipopolysaccharide-induced nitric oxide and tumour necrosis factor production in murine microglia and macrophages. Mol Nutr Food Res 52 (2008) 427-438
39. Simon S.L., Dacey J., Glynn S., Rawson R., and Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 27 (2004) 59-66
40. Simon S.L., Domier C., Carnell J., Brethen P., Rawson R., and Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict 9 (2000) 222-231
41. Simon S.L., Domier C.P., Sim T., Richardson K., Rawson R.A., and Ling W. Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21 (2002) 61-74
42. Thomas D.M., and Kuhn D.M. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J Neurochem 92 (2005) 790-797
43. Trouillas P., Marsal P., Svobodová A., Vostálová J., Gazák R., Hrbác J., et al. Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J Phys Chem A 112 (2008) 1054-1063
44. Verkes R.J., Gijsman H.J., Pieters M.S., Schoemaker R.C., de Visser S., Kuijpers M., et al. Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berl) 153 (2001) 196-202
45. Wang M.J., Lin W.W., Chen H.L., Chang Y.H., Ou H.C., Kuo J.S., et al. Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur J Neurosci 16 (2002) 2103-2112
46. Wood M.D., and Wren P.B. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Prog Brain Res 172 (2008) 213-230
47. Yamada K., Noda Y., Nakayama S., Komori Y., Sugihara H., Hasegawa T., et al. Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br J Pharmacol 115 (1995) 852-858
48. Yamamoto B.K., and Cooperman M.A. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J Neurosci 14 (1994) 4159-4166